Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

WATCH: Inventor of mRNA Vaccine Sounds the Alarm of Lipid Nanoparticles from Experimental COVID-19 Vaccines Accumulating in Vital Organs


62,533 views

A couple of weeks ago, Dr. Byram Bridle relayed research of the horrific findings that the spike protein from the experimental jabs was accumulating in organs.

Instead of remaining at the injection site in the shoulder, the spike protein frequently becomes biologically active and circulates in the bloodstream.

As a result, the spike protein settles in large amounts inside critical organs and tissues.

Dr. Byram Bridle was censored for his revelations, but he’s not alone in his assertions.

Dr. Robert W. Malone is the inventor of mRNA vaccine technology and he recently joined Brett Brownstein, Ph.D for an episode of the Dark Horse Podcast.

Malone expressed his concerns about the findings made in the study referenced by Bridle.

He reiterated that the lipid nanoparticles responsible for producing the spike protein were accumulating in organs at alarming rates.

In particular, the concentrations in the ovaries were extremely high.

Check out this clip from Malone on the Dark Horse Podcast:

Children’s Health Defense reported:

They also discuss the lack of proper animal studies for the new mRNA vaccines, and the theory, espoused by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce ever more transmissible and potentially deadly variants.

As The Defender reported June 3, Bridle received a copy of a Japanese biodistribution study — which had been kept from the public — as a result of a freedom of information request made to the Japanese government for Pfizer data.

Prior to the study’s disclosure, the public was led to believe by regulators and vaccine developers that the spike protein produced by mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically active — even though regulators around the world had a copy of the study which showed otherwise.

The biodistribution study obtained by Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid muscle where they were injected as the vaccine’s developers claimed would happen, but circulated throughout the body and accumulated in large concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and  — in “quite high concentrations” — in the ovaries.

The mRNA — or messenger RNA — is what tells the body to manufacture the spike protein. The lipid nanoparticles are like the “boxes” the mRNA is shipped in, according to Malone. “If you find lipid nanoparticles in an organ or tissue, that tells you the drug got to that location,” Malone explained.

According to the data in the Japanese study, lipid nanoparticles were found in the whole blood circulating throughout the body within four hours, and then settled in large concentrations in the ovaries, bone marrow and lymph nodes.

Malone said there needed to be monitoring of vaccine recipients for leukemia and lymphomas as there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signals often don’t show up for six months to three or nine years down the road, he said.

Usually, signals like this are picked up in animal studies and long-term clinical trials, but this didn’t happen with mRNA vaccines, Malone said.

Malone said there are two adverse event signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). One of them is thrombocytopenia — not having enough platelets, which are manufactured in the bone marrow. The other is reactivation of latent viruses.

Malone found the ovarian signal perplexing because there is no accumulation in the testes.

Malone said the original data packages contained this biodistribution information. “This data has been out there a long time” within the protected, non-disclosed, purview of the regulators across the world, he said.

According to Malone, the FDA knew the COVID spike protein was biologically active and could travel from the injection site and cause adverse events, and that the spike protein, if biologically active, is very dangerous.

In fact, Malone was one of many scientists to warn the FDA about the dangers of the free spike protein.

Malone also made this comment on Twitter referencing the effectiveness of Ivermectin:

They said trust the scientists, right?

Will they trust the inventor of the mRNA vaccine technology?



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!